(HIPO) Hippo Holdings - Ratings and Ratios
Homeowners, Auto, Flood, Earthquake, Pet
HIPO EPS (Earnings per Share)
HIPO Revenue
Description: HIPO Hippo Holdings September 11, 2025
Hippo Holdings Inc. (NYSE:HIPO) is a technology‑enabled insurer that sells property‑and‑casualty (P&C) coverage to both residential and commercial customers across the United States. The firm’s business model is built around three operating segments: a Services arm that provides ancillary home‑care products (e.g., service contracts, health‑check inspections, and advice), an Insurance‑as‑a‑Service (IaaS) platform that partners with licensed carriers to underwrite policies on Hippo’s digital front‑end, and the Hippo Home Insurance Program, which writes homeowner policies directly under its own carrier license.
Key revenue drivers include: (1) customer acquisition cost (CAC) efficiency – Hippo claims its AI‑driven underwriting and marketing stack yields CACs 30‑40 % lower than legacy insurers; (2) policy‑level retention (renewal) rates – industry benchmarks for digital P&C range from 70‑80 % YoY, and Hippo has reported renewal rates near the high end of that band; (3) cross‑sell penetration of ancillary services, which historically adds 10‑15 % incremental premium per household. Assuming these levers hold, the company’s top‑line growth outlook is anchored to the expanding U.S. homeowner market (≈ 140 M policies) and the rising consumer appetite for bundled, tech‑first insurance experiences.
From a profitability standpoint, the primary metrics to watch are the combined ratio (loss + expense) and the loss ratio. Hippo’s disclosed combined ratio has hovered around 95 % in recent quarters, implying an underwriting profit margin of roughly 5 % before investment income. The loss ratio is sensitive to catastrophe exposure (wildfire, hurricane, and flood events) and to the company’s underwriting aggressiveness in pricing newer risk segments such as pet and flood coverage. A sustained combined ratio below 100 % would support cash‑flow positivity, whereas a spike above 105 % would signal underwriting stress.
Capital efficiency is another critical KPI. Hippo’s balance sheet is relatively light, relying on reinsurance arrangements to manage tail risk. The company’s leverage (debt‑to‑equity) is modest, but its cash burn remains a concern; free cash flow conversion has been negative in most recent periods, reflecting continued investment in technology, sales, and regulatory licensing. A break‑even cash‑flow timeline of 12‑18 months is a common analyst target, contingent on maintaining high renewal rates and scaling ancillary services.
Macro‑level economic drivers that could materially affect Hippo’s performance include: (a) U.S. housing market dynamics – higher home prices and construction activity expand the addressable pool of new homeowners; (b) interest‑rate environment – rising rates increase the cost of capital for insurers and can depress discretionary spending on optional coverage; (c) climate‑risk trends – increasing frequency of severe weather events raises expected loss severity and may pressure reinsurance pricing; and (d) regulatory landscape – state‑by‑state licensing requirements can slow geographic expansion and add compliance costs.
Competitive pressures are intense. Hippo competes with legacy carriers that are digitizing (e.g., State Farm, Allstate) and with pure‑play insurtechs (e.g., Lemonade, Root). Market share gains will depend on Hippo’s ability to sustain lower CAC, faster policy issuance (often under 5 minutes), and superior post‑sale service—attributes that are quantifiable through Net Promoter Score (NPS) and average handling time metrics, which the firm has not publicly disclosed.
In summary, Hippo’s value proposition rests on leveraging AI‑driven underwriting and a vertically integrated digital platform to capture a higher‑margin slice of the U.S. P&C market. The upside hinges on maintaining sub‑industry CAC, high renewal rates, and a combined ratio under 100 %; downside risks stem from elevated catastrophe loss experience, cash‑flow deficits, and the need to scale ancillary services profitably. Investors should monitor quarterly updates on loss ratios, reinsurance costs, and cash‑burn trends to assess whether the company is on track to transition from growth‑phase spending to sustainable profitability.
HIPO Stock Overview
| Market Cap in USD | 921m |
| Sub-Industry | Insurance Brokers |
| IPO / Inception | 2021-08-03 |
HIPO Stock Ratings
| Growth Rating | 46.3% |
| Fundamental | 72.1% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 38.4% |
| Analyst Rating | 4.0 of 5 |
HIPO Dividends
Currently no dividends paidHIPO Growth Ratios
| Growth Correlation 3m | 64.1% |
| Growth Correlation 12m | 43.9% |
| Growth Correlation 5y | -44.4% |
| CAGR 5y | 34.83% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.53 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.43 |
| Sharpe Ratio 12m | 0.86 |
| Alpha | 49.65 |
| Beta | 1.567 |
| Volatility | 60.98% |
| Current Volume | 404k |
| Average Volume 20d | 107.7k |
| Stop Loss | 36.2 (-4.4%) |
| Signal | -0.76 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-10.7m TTM) > 0 and > 6% of Revenue (6% = 25.5m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 8.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.20% (prev 66.18%; Δ -28.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 29.5m > Net Income -10.7m (YES >=105%, WARN >=100%) |
| Net Debt (-144.9m) to EBITDA (6.10m) ratio: -23.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (26.0m) change vs 12m ago 5.64% (target <= -2.0% for YES) |
| Gross Margin 7.81% (prev 20.01%; Δ -12.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.27% (prev 31.99%; Δ 0.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.01 (EBITDA TTM 6.10m / Interest Expense TTM 46.8m) >= 6 (WARN >= 3) |
Altman Z'' -2.69
| (A) 0.09 = (Total Current Assets 426.0m - Total Current Liabilities 267.9m) / Total Assets 1.71b |
| (B) -0.77 = Retained Earnings (Balance) -1.32b / Total Assets 1.71b |
| (C) 0.04 = EBIT TTM 47.1m / Avg Total Assets 1.32b |
| (D) -0.96 = Book Value of Equity -1.32b / Total Liabilities 1.37b |
| Total Rating: -2.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.05
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 6.74% = 3.37 |
| 3. FCF Margin 8.26% = 2.06 |
| 4. Debt/Equity 0.16 = 2.49 |
| 5. Debt/Ebitda -23.75 = 2.50 |
| 6. ROIC - WACC (= 2.03)% = 2.54 |
| 7. RoE -3.18% = -0.53 |
| 8. Rev. Trend 98.23% = 7.37 |
| 9. EPS Trend 74.98% = 3.75 |
What is the price of HIPO shares?
Over the past week, the price has changed by +2.38%, over one month by +5.49%, over three months by +36.84% and over the past year by +64.57%.
Is Hippo Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HIPO is around 34.54 USD . This means that HIPO is currently overvalued and has a potential downside of -8.75%.
Is HIPO a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HIPO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.7 | 2.2% |
| Analysts Target Price | 38.7 | 2.2% |
| ValueRay Target Price | 39.4 | 4.2% |
HIPO Fundamental Data Overview November 04, 2025
P/S = 2.166
P/B = 2.6955
Beta = 1.567
Revenue TTM = 425.0m USD
EBIT TTM = 47.1m USD
EBITDA TTM = 6.10m USD
Long Term Debt = 47.9m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 54.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -144.9m USD (from netDebt column, last quarter)
Enterprise Value = 520.5m USD (920.5m + Debt 54.0m - CCE 454.0m)
Interest Coverage Ratio = 1.01 (Ebit TTM 47.1m / Interest Expense TTM 46.8m)
FCF Yield = 6.74% (FCF TTM 35.1m / Enterprise Value 520.5m)
FCF Margin = 8.26% (FCF TTM 35.1m / Revenue TTM 425.0m)
Net Margin = -2.52% (Net Income TTM -10.7m / Revenue TTM 425.0m)
Gross Margin = 7.81% ((Revenue TTM 425.0m - Cost of Revenue TTM 391.8m) / Revenue TTM)
Gross Margin QoQ = 34.10% (prev -11.15%)
Tobins Q-Ratio = 0.31 (Enterprise Value 520.5m / Total Assets 1.71b)
Interest Expense / Debt = 0.56% (Interest Expense 300.0k / Debt 54.0m)
Taxrate = 2.50% (100.0k / 4.00m)
NOPAT = 45.9m (EBIT 47.1m * (1 - 2.50%))
Current Ratio = 1.59 (Total Current Assets 426.0m / Total Current Liabilities 267.9m)
Debt / Equity = 0.16 (Debt 54.0m / totalStockholderEquity, last quarter 332.5m)
Debt / EBITDA = -23.75 (Net Debt -144.9m / EBITDA 6.10m)
Debt / FCF = -4.13 (Net Debt -144.9m / FCF TTM 35.1m)
Total Stockholder Equity = 335.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.63% (Net Income -10.7m / Total Assets 1.71b)
RoE = -3.18% (Net Income TTM -10.7m / Total Stockholder Equity 335.9m)
RoCE = 12.27% (EBIT 47.1m / Capital Employed (Equity 335.9m + L.T.Debt 47.9m))
RoIC = 13.20% (NOPAT 45.9m / Invested Capital 347.9m)
WACC = 11.17% (E(920.5m)/V(974.5m) * Re(11.79%) + D(54.0m)/V(974.5m) * Rd(0.56%) * (1-Tc(0.03)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.81%
[DCF Debug] Terminal Value 56.71% ; FCFE base≈35.1m ; Y1≈24.0m ; Y5≈11.8m
Fair Price DCF = 5.59 (DCF Value 140.0m / Shares Outstanding 25.0m; 5y FCF grow -37.16% → 3.0% )
EPS Correlation: 74.98 | EPS CAGR: 253.2% | SUE: 0.57 | # QB: 0
Revenue Correlation: 98.23 | Revenue CAGR: 62.81% | SUE: 0.80 | # QB: 0
Additional Sources for HIPO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle